AIM Schedule 1 - Biofutures International Plc (6817Z)
11 3월 2013 - 6:55PM
UK Regulatory
TIDMBIP
RNS Number : 6817Z
AIM
11 March 2013
ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION
IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM
RULES")
--------------------------------------------------------------------------
COMPANY NAME:
--------------------------------------------------------------------------
Graphene NanoChem Plc (formerly Biofutures International Plc
("Biofutures" or "the Company")
--------------------------------------------------------------------------
COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY
TRADING ADDRESS (INCLUDING POSTCODES) :
--------------------------------------------------------------------------
Academy House
London Road
Camberley
Surrey
GU15 3HL
--------------------------------------------------------------------------
COUNTRY OF INCORPORATION:
--------------------------------------------------------------------------
England & Wales
--------------------------------------------------------------------------
COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED
BY AIM RULE 26:
--------------------------------------------------------------------------
www.biofuturesplc.com until Admission, www.graphenenanochem.com
thereafter
--------------------------------------------------------------------------
COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR,
IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING
POLICY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE
TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED:
--------------------------------------------------------------------------
Biofutures is the parent company of Zurex Corporation Sdn.
Bhd. ("Zurex"), a company incorporated in Malaysia. Zurex owns
and operates a 200,000 metric tones per annum palm oil refinery
in Lahad Datu, Sabah, Malaysia and has a licence to manufacture
biodiesel from palm oil. Zurex's refinery sits on a 14 acre
plot of land in POIC Lahad Datu, Sabah, Malaysia. POIC is an
entity set up and owned by the State Government of Sabah, Malaysia
to spearhead palm oil downstream processing in order to add
value to its growing oil palm industry and to create more jobs
and business opportunities. Biofutures was admitted to trading
on AIM in 2006.
On 10 December 2012, the Company announced that it had entered
into a conditional agreement to acquire Platinum NanoChem Sdn.
Bhd. ("Platinum NanoChem") which constitutes a reverse takeover
under Rule 14 of the AIM Rules and is therefore conditional,
inter alia, upon the approval of Shareholders at a General
Meeting expected to be held on 25 March 2013. Following Admission,
the merger of Biofutures and Platinum will result in an enlarged
integrated business. The enlarged group is expected to be named
Graphene NanoChem Plc.
Platinum is a privately held global nanotechnology company
whose business model is to design, formulate, manufacture and
market a range of speciality chemicals and advanced materials
(including products enhanced by a range of graphitic nanomaterials
("Graphene") which Platinum produces) that demonstrate improved
performance characteristics when compared to existing products
within the chemicals and materials markets. It has a revenue-generating
range of high quality chemical products derived from readily
available low-cost wastes from the palm oil industry, alongside
an active commercialisation strategy for niche opportunities
within the global market for Graphene applications. Its existing
portfolio and pipeline of products are based on two core nanotechnology
platforms which are protected by a network of patent families,
licences and specialist knowledge.
--------------------------------------------------------------------------
DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS
AS TO TRANSFER OF THE SECURITIES (i.e. where known, number
and type of shares, nominal value and issue price to which
it seeks admission and the number and type to be held as treasury
shares):
--------------------------------------------------------------------------
116,536,536 ordinary shares of 20 pence each, following a proposed
consolidation of the existing issued ordinary shares of 1 pence
each on a one for twenty basis
Placing Price: 140 pence
--------------------------------------------------------------------------
CAPITAL TO BE RAISED ON ADMISSION (IF APPLICABLE) AND ANTICIPATED
MARKET CAPITALISATION ON ADMISSION:
--------------------------------------------------------------------------
GBP32.5 million to be raised on Admission
Market capitalisation of the Company at the Placing Price at
Admission GBP163.2 million
--------------------------------------------------------------------------
PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:
--------------------------------------------------------------------------
73.56%
--------------------------------------------------------------------------
DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH
THE AIM COMPANY HAS APPLIED OR AGREED TO HAVE ANY OF ITS SECURITIES
(INCLUDING ITS AIM SECURITIES) ADMITTED OR TRADED:
--------------------------------------------------------------------------
None
--------------------------------------------------------------------------
FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS
(underlining the first name by which each is known or including
any other name by which each is known):
--------------------------------------------------------------------------
Directors:
Dr "Joe" Wong Kai Fatt - Chief Executive Officer, Proposed
Executive Director
Dr Patrick Dennis Howes - Non-executive Chairman, Proposed
Non-executive Director
David John Long - Non-executive Director
Proposed Directors:
Tan Sri Abi Musa - Proposed Non-executive Chairman
Dato' Larry Gan - Proposed Non-executive Director
Alan Cleverly OBE - Proposed Non-executive Director
Dato' Jespal Deol - Proposed Chief Executive Officer
Sushil Sidhu - Proposed Chief Financial Officer
--------------------------------------------------------------------------
FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED
AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER
ADMISSION (underlining the first name by which each is known
or including any other name by which each is known):
--------------------------------------------------------------------------
Before admission:
Significant Shareholder % of Issued Share
Capital
------------------------------------ ------------------
Henderson Global Investors Limited 20.02
------------------------------------ ------------------
Stoutman Holdings Limited 13.26
------------------------------------ ------------------
Dr "Joe" Wong Kai Fatt 8.01
------------------------------------ ------------------
Allianz SE 7.00
------------------------------------ ------------------
Judith Catherine Carter 4.24
------------------------------------ ------------------
AXA Investment Managers UK Limited 3.75
------------------------------------ ------------------
After admission:
Significant Shareholder % of Issued Share
Capital
------------------------------------ ------------------
Platinum Energy Global Sdn. Bhd. 24.66
------------------------------------ ------------------
Dato' "Simon" Foong Choong Heng(1) 14.67
------------------------------------ ------------------
Rampai Teknologi Sdn. Bhd. 7.88
------------------------------------ ------------------
Green Ethics Capital Sdn. Bhd. 3.94
------------------------------------ ------------------
Dato' "Larry" Gan Nyap Liou @ Gan
Nyap Liow 5.16
------------------------------------ ------------------
MSG Commercial Limited 3.77
------------------------------------ ------------------
Plug & Play Technology Sdn. Bhd. 3.73
------------------------------------ ------------------
Investec Asset Management Limited 3.37
------------------------------------ ------------------
(1) Dato' Foong Choong Heng's interest comprises 7,913,754
Consolidated Ordinary Shares held directly, and 9,181,857 Consolidated
Ordinary Shares held by Rampai Teknologi Sdn. Bhd., which is
beneficially owned by him and his family.
--------------------------------------------------------------------------
NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE
2, PARAGRAPH (H) OF THE AIM RULES:
--------------------------------------------------------------------------
None
--------------------------------------------------------------------------
(i) ANTICIPATED ACCOUNTING REFERENCE DATE
(ii) DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION
DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited
interim financial information)
(iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS
PURSUANT TO AIM RULES 18 AND 19:
--------------------------------------------------------------------------
(i) 31 December
(ii) 30 November 2012 (in relation to the Platinum Group)
(iii) Next three results to be published:
(a) Annual results for the year ended 31 December 2012 by 30
June 2013
(b) Interim results for the 6 months ended 30 June 2013 by
30 September 2013
(c) Annual results for the year ended 31 December 2013 by 30
June 2014
--------------------------------------------------------------------------
EXPECTED ADMISSION DATE:
--------------------------------------------------------------------------
26 March 2013
--------------------------------------------------------------------------
NAME AND ADDRESS OF NOMINATED ADVISER:
--------------------------------------------------------------------------
Before Admission:
Daniel Stewart & Company plc
Becket House
36 Old Jewry
London
EC2R 8DD
After Admission:
Panmure Gordon (UK) Limited
One New Change
London
EC4M 9AF
--------------------------------------------------------------------------
NAME AND ADDRESS OF BROKER:
--------------------------------------------------------------------------
Panmure Gordon (UK) Limited
One New Change
London
EC4M 9AF
--------------------------------------------------------------------------
OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE
(POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE
AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL
DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:
--------------------------------------------------------------------------
A copy of the admission document containing full details of
the applicant and the admission of its securities will be available
at the Company's website, www.biofuturesplc.com (until Admission)
or www.graphenenanochem.com (after Admission)
--------------------------------------------------------------------------
DATE OF NOTIFICATION:
--------------------------------------------------------------------------
11 March 2013
--------------------------------------------------------------------------
NEW/ UPDATE:
--------------------------------------------------------------------------
NEW
--------------------------------------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
PAALIFSAVVILLIV
Biofutures (LSE:BIP)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Biofutures (LSE:BIP)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Biofutures (London Stock Exchange)의 실시간 뉴스: 최근 기사 0
More Biofutures News Articles